Ian Schofield
Executive Editor
Latest From Ian Schofield
UK Prepares To Roll Out Expanded Subscription Model For Antimicrobials
Under the new scheme, contract payments for antimicrobial products of up to £20m a year will be based on clinical award criteria with a points-based scoring system derived from experience with the pilot scheme.
EU Parliament Waters Down Planned Antimicrobial Voucher Scheme
In the second in a series of articles on amendments to the EU pharmaceutical reform proposals, the Pink Sheet looks at changes made by the European Parliament to the “transferable exclusivity voucher” and its ideas for a milestone payment and subscription-model scheme.
Pandemic Treaty Talks Go Up To The Wire
The talks are still tough, with the Pathogen Access and Benefit Sharing proposal proving the most difficult aspect of the treaty, but there is cautious optimism that some form of agreement may be reached this week.
Swissmedic Gets New Grant For Regulatory Strengthening In LMICs
The Swiss agency says the aim of the agreement is to bring “high-quality, life-saving medicines to patients as quickly as possible.”
Industry Slates Decision To Exempt Parallel Importers From New Danish Stockpile Rules
The bill on new rules on companies holding minimum stock levels for “critical medicines” has been amended but is still likely to take effect at the beginning of July.
EU Biosimilar Filings, Opinions And Approvals
A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.